
Value-based healthcare frameworks align reimbursement and care delivery with clinical outcomes and patient-relevant quality measures rather than activity volumes. Outcome-based contracts, integrated practice units, and bundled payment models are progressively adopted in elective surgery, oncology, and chronic disease management. Life science companies are increasingly designing products and evidence packages to support value demonstration to payers and HTA bodies.